MAMU
MR

Marathon Asset Management (UK)’s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A MR Stock Holding History

Marathon Asset Management (UK)’s Portfolio MR Stock Details MR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-775,356
Closed -$21M – 103
2015
Q4 		$21M Sell
775,356
-2,865
-0.4% -$73.8K 0.48% 66
2015
Q3 		$17M Buy
778,221
+982
+0.1% +$25.1K 0.41% 65
2015
Q2 		$22.2M Sell
777,239
-8,236
-1% -$240K 0.51% 59
2015
Q1 		$21.5M Sell
785,475
-179,406
-19% -$4.94M 0.52% 58
2014
Q4 		$25.5M Sell
964,881
-1,004
-0.1% -$29.4K 0.61% 52
2014
Q3 		$29.1M Buy
965,885
+7,492
+0.8% +$232K 0.71% 49
2014
Q2 		$30.2M Buy
958,393
+62,892
+7% +$2M 0.75% 49
2014
Q1 		$29.4M Buy
895,501
+984
+0.1% +$34.4K 0.75% 51
2013
Q4 		$32.5M Sell
894,517
-308,444
-26% -$12M 0.8% 46
2013
Q3 		$46.8M Sell
1,202,961
-257,202
-18% -$10.4M 1.13% 37
2013
Q2 		$55.3M Buy
+1,460,163
New +$57.7M 1.31% 35

Other funds holding MR

Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Marathon Asset Management (UK)'s MR Position: Q1 2016 in Review

Marathon Asset Management (UK) sold out of MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A (MR) in Q1 2016, closing a stake of 775,356 shares — an estimated $21M sold.

Marathon Asset Management (UK) first reported a position in MR in Q2 2013 and held it in 11 quarters. The position peaked at $55.3M in Q2 2013. 2 funds tracked by Wall St. Rank hold MR as of Q1 2016.

  • Marathon Asset Management (UK) reported no remaining MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position as of Q1 2016 after selling out during the quarter.
  • Marathon Asset Management (UK) sold 775,356 MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A shares in Q1 2016, an estimated $21M.
  • Marathon Asset Management (UK) first reported a position in MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A in Q2 2013 and held it in 11 quarters.
  • Marathon Asset Management (UK)'s MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A position peaked at $55.3M in Q2 2013.
  • 2 funds tracked by Wall St. Rank held MINDRAY MED INTL LTD SPONSORED ADR REPSTG CL A as of Q1 2016.

Based on Marathon Asset Management (UK)'s 13F filing for Q1 2016, filed 20 Apr 2016.